Metal Binder Jetting
Automotive Polymers

Remote Controlled 3D Printed Pills to Inhibit Cancer Growth

Share this Article

Central to the treatment of most patients, medication in the form of pills and complex drug delivery systems is expected to change drastically in the coming years too as these items can be 3D printed quickly, affordably, and in a variety of shapes, sizes, and colors—moving from the conceptual stage to reality with the FDA approval of Aprecia, an epilepsy pill. The trend has continued from there, and although perhaps a bit more slowly than expected, many researchers continue to make strides.

Now, engineers and pharmaceutical scientists from the University of Sussex and the University of Texas at Austin have created a unique method for drug delivery, featuring remote control. 3D-printed pills, in capsule form, are controlled by magnetic fields and triggered for drug delivery to patients as needed. This could mean improved treatment for patients with serious diseases:

“The device delivers enhanced efficacy and safety through optimal drug distribution and absorption in the targeted location at the (sub)cellular level. This device has the potential to be used in treatments for cancer, diabetes, pain, and myocardial infarction which require variable release kinetics where patients’ suffer from discomfort or inconvenience if they currently rely on untunable monotonic drug treatment,” said Professor Ali Nokhodchi, head of Pharmaceutics Research Lab at the University of Sussex School of Life Sciences and corresponding author.

Fabrication of the device reservoir using a standard 3D printing machine.

With the use of magnets, as outlined in “Novel 3D printed device with integrated macroscale magnetic field triggerable anti-cancer drug delivery system,” medication could be directed toward areas requiring drug delivery, and then applied closely.

“The device offers the potential for personalized treatment through the loading of a given drug in a particular concentration and releasing it within different dosage patterns. All results confirmed that the device can provide a safe, long-term, triggerable and reutilizable way for localized disease treatments such as cancer,” said Kejing Shi, doctoral researcher in the University of Sussex’s School of Life Sciences and lead author of the study.

Such targeted delivery could allow patients to forego aggressive treatments like chemotherapy, not only weakening patients but also harming other cells. Errors in dosing could be eliminated also—one of the major reasons for bad side effects.

“Advancing this process further, we could create different compartments in the capsule with different sponges or employ other techniques where the macroporous sponge properties can be tailored to hold two or more substances without being mixed which could deliver more complex courses of treatment,” said Dr. Rodrigo Aviles-Espinosa.

Fabrication of the device reservoir using a standard 3D printing machine.

What do you think of this news? Let us know your thoughts! Join the discussion of this and other 3D printing topics at 3DPrintBoard.com.

[Source / Images: University of Sussex]

Share this Article


Recent News

3D Printing News Unpeeled, Live with Joris Peels Monday 15th of August

Velo3D CEO Benny Buller on Impressive Q2 Earnings – AMS Focus



Categories

3D Design

3D Printed Art

3D Printed Food

3D Printed Guns


You May Also Like

3D Printing News Unpeeled, Live with Joris Peels Friday 12th of August

Today we will be talking about a model of a cranium, Prellis Biologics new raise, 3D printing actuators for a hand that moves like a human one as well as...

Metal 3D Printing Firm Velo3D Announces Impressive Q2 Earning

US financial markets appear to be in a state of limbo. For one thing, there are few clear opinions circulating concerning the question as to whether the American economy is,...

3D Printing News Unpeeled, Live with Joris Peels Thursday 11th of August

Today we’re going to discuss 3D printed sunglasses from Givenchy, 3D printing drone swarms, more sustainable 3D printing materials for buildings by ORNL, 3D printing earnings season and more.  

Stratasys Goes on the Record on Buying Covestro 3D Printing Materials Unit

In light of the recent acquisition of Covestro’s additive manufacturing (AM) business by Stratasys, we interviewed executive vice president of Product Strategy and Corporate Development at Stratasys Omer Krieger and...